Press Releases - 2021-10-04

Date	Title	Company
04-Oct-2021	UK Medicines and Healthcare Products Regulatory Agency (MHRA) issues a conditional Marketing Authorisation of TEPMETKO® (tepotinib) for the treatment of advanced NSCLC with METex14 Skipping Alterations	Say Communications
04-Oct-2021	National Cancer Institute Selects ImmunityBio’s N-803 IL-15 Receptor Agonist to Combine with Keytruda in 700-Site Lung-MAP Clinical Trial of a Chemo-Free Therapy	Businesswire
04-Oct-2021	Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer	Businesswire
04-Oct-2021	Defibrillators Market was valued at US$ 11.8 million in 2015 and is projected to expand at a CAGR of 6.0% during the forecast period 2024	CDN Newswire
04-Oct-2021	Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Australia	Businesswire
04-Oct-2021	Adult Diapers Market Analysis Survey Growth (CAGR of 11.8%) by Top Companies, Consumption by Regional Data, Trends by Type and Use, Predictive Analytics Up to 2025	CDN Newswire
04-Oct-2021	Adjustable Bed Market \| Analysis by Type and Application\| Study Objectives Industry Perspective and Forecasted Market Size by Regions till 2024	CDN Newswire
04-Oct-2021	Global Defibrillators Market was valued at US$ 11.8 million in 2015 and is projected to expand at a CAGR of 6.0% during the forecast period 2024	CDN Newswire
04-Oct-2021	Blood Glucose Monitors Market with CAGR Of 6.8%, Analysis, Recent Trends and Forecast Up To 2027\| Regional Data Consumption, Research and Growth	CDN Newswire
04-Oct-2021	Rapid Cancer Tests Kits Market Growth Analysis, Share, and Regional Data Consumption, Survey and Growth, Regional Demand, Key Player Types and Analysis and Survey Forecast – 2026	CDN Newswire
04-Oct-2021	PharmiWeb.Jobs Welcomes Mettler-Toledo	PharmiWeb.Jobs
04-Oct-2021	Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel®)	Businesswire
04-Oct-2021	Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland	Thermo Fisher Scientific
04-Oct-2021	Boston Pharmaceuticals Doses First Patient in Phase 2a Clinical Trial of BOS-580 for NASH	Businesswire
04-Oct-2021	Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs	Businesswire
04-Oct-2021	Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies	Businesswire
04-Oct-2021	LianBio Appoints Michael Humphries as Chief Scientific Advisor	Businesswire
04-Oct-2021	SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19	Businesswire
04-Oct-2021	MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing Tri-specific Nanobody® Sonelokimab	Businesswire
04-Oct-2021	SQZ Biotechnologies to Present New Data at the Society for Immunotherapy of Cancer Annual Meeting	Businesswire